2-amino-1-(3-(3-(3-(trifluoromethyl)phenyl)ureido)phenyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide

ID: ALA3321821

PubChem CID: 118386999

Max Phase: Preclinical

Molecular Formula: C25H18F3N7O2

Molecular Weight: 505.46

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  NC(=O)c1c(N)n(-c2cccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c2)c2nc3ccccc3nc12

Standard InChI:  InChI=1S/C25H18F3N7O2/c26-25(27,28)13-5-3-6-14(11-13)31-24(37)32-15-7-4-8-16(12-15)35-21(29)19(22(30)36)20-23(35)34-18-10-2-1-9-17(18)33-20/h1-12H,29H2,(H2,30,36)(H2,31,32,37)

Standard InChI Key:  FIIMQMJOBYXPHE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   10.6573   -2.5445    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3718   -2.1321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3718   -1.3071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6573   -0.8946    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9429   -1.3071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2284   -0.8946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5139   -1.3071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5139   -2.1321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2284   -2.5445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9429   -2.1321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1564   -2.3870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1564   -1.0521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6414   -1.7196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4114   -0.2674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8594    0.3461    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2083   -0.0539    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4114   -3.1716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8594   -3.7847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1143   -4.5694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9213   -4.7409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4733   -4.1278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2184   -3.3432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4664   -1.7196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.2803   -4.2993    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.5352   -5.0839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3422   -5.2555    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9832   -5.6970    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5971   -6.0401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0430   -6.6494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2975   -7.4334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1052   -7.6055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6581   -6.9875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4008   -6.2059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4657   -7.1562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7234   -7.9399    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.0156   -6.5411    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.2876   -7.1542    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  1 10  1  0
  5 10  1  0
 12 13  2  0
 11 13  1  0
  2 11  1  0
  3 12  1  0
 14 15  2  0
 14 16  1  0
 12 14  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 17 22  2  0
 11 17  1  0
 13 23  1  0
 21 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 32 34  1  0
 34 35  1  0
 34 36  1  0
 34 37  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3321821

   2-Amino-1-[3-[[3-(trifluoromethyl)phenyl]carbamoylamino]phenyl]pyrrolo[3,2-b]quinoxaline-3-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 505.46

Molecular Weight (Monoisotopic): 505.1474

AlogP: 4.92

#Rotatable Bonds: 4

Polar Surface Area: 140.95

Molecular Species: NEUTRAL

HBA: 6

HBD: 4

#RO5 Violations: 1

HBA (Lipinski): 9

HBD (Lipinski): 6

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 11.38

CX Basic pKa: 1.01

CX LogP: 4.82

CX LogD: 4.82

Aromatic Rings: 5

Heavy Atoms: 37

QED Weighted: 0.27

Np Likeness Score: -1.65

References

1. Unzue A, Dong J, Lafleur K, Zhao H, Frugier E, Caflisch A, Nevado C..  (2014)  Pyrrolo[3,2-b]quinoxaline derivatives as types I1/2 and II Eph tyrosine kinase inhibitors: structure-based design, synthesis, and in vivo validation.,  57  (15): [PMID:25076195] [10.1021/jm5009242]

Source

Source(1):

• Scientific Literature